Classic Benjamin Graham Stock Screener
Free Value Investing for Intelligent Investors across Global Equity Markets, as recommended by Warren Buffett.
| Company Name | MIC | HQ | Fiscal Year | Last Updated | Curr Code | Previous Close | Graham Number | Graham Number(%) | NCAV/ NetNet | NCAV/ NetNet(%) | Graham Grade | Intrinsic Value | Intrinsic Value(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 91 | Adverum Biotechnologies Inc (0HA3.L) | XLON | US | 2023-12-31 | 3 days ago | USD | 9.70 | 0.00 | 0.00% | 13.05 | 134.51% | Ungraded | 0.00 | 0.00% |
| 92 | Adverum Biotechnologies Inc (ADVM) | XNAS | US | 2023-12-31 | 3 days ago | USD | 9.61 | 0.00 | 0.00% | 13.05 | 135.77% | Ungraded | 0.00 | 0.00% |
| 93 | ADVFN PLC (AFN.L) | XLON | GB | 2023-06-30 | 1 week ago | GBP | 0.11 | 0.00 | 0.00% | 0.09 | 84.68% | Ungraded | 0.00 | 0.00% |
| 94 | AE Multi Holdings Bhd (AEM.KL) | XKLS | MY | 2023-03-31 | 11 hours ago | MYR | 0.14 | 0.00 | 0.00% | 1.87 | 1,338.11% | Ungraded | 0.00 | 0.00% |
| 95 | AEE Gold AG (AEE1.DU) | XDUS | DE | 2019-12-31 | 1 week ago | EUR | 0.90 | 0.22 | 23.96% | 0.62 | 68.83% | Ungraded | 0.00 | 0.00% |
| 96 | Aeglea Bio Therapeutics Inc (AGLE) | XNAS | US | 2022-12-31 | 5 months ago | USD | 11.04 | 0.00 | 0.00% | 399.04 | 3,614.48% | Ungraded | 0.00 | 0.00% |
| 97 | Aeterna Zentaris Inc (AEZS) | XNAS | CA | 2023-12-31 | 3 days ago | USD | 7.84 | 0.00 | 0.00% | 58.02 | 740.01% | Ungraded | 0.00 | 0.00% |
| 98 | Aethlon Medical Inc (AEMD) | XNAS | US | 2023-03-31 | 3 days ago | USD | 1.18 | 0.00 | 0.00% | 55.00 | 4,661.02% | Ungraded | 0.00 | 0.00% |
| 99 | Aeva Technologies Inc (AEVA) | XNYS | US | 2023-12-31 | 3 days ago | USD | 3.53 | 0.00 | 0.00% | 19.12 | 541.51% | Ungraded | 0.00 | 0.00% |
| 100 | AEye Inc (LIDR) | XNAS | US | 2023-12-31 | 3 days ago | USD | 1.15 | 0.00 | 0.00% | 2.29 | 199.27% | Ungraded | 0.00 | 0.00% |